BIONTECH : Morgan Stanley reiterates its Neutral rating : vi

In a research note published by Terence Flynn, Morgan Stanley gives a Neutral rating to the stock. The target price is decreased from USD 150 to USD 124. | May 10, 2023

Related Keywords

Terence Flynn , Morgan Stanley , Biontech Se Stock Exchange , News , Information , Press Release , N , Research , Vote , Published , Y , Terence , Organ , Tanley , Lives , Eutral , Eating , O , The , Target , Price , Us , Ecreased , Rom , Sd , 50 , Sd Bntx Us09075v1026 ,